Master One Thing - Rapamycin Longevity Series cover image

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

Master One Thing - Rapamycin Longevity Series

00:00

RTB101 Trials: Successes and a Phase 3 Failure

Joan summarizes RTB101's phase 2b success, phase 3 failure, and lessons about endpoints and population selection.

Play episode from 42:16
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app